en

PRODUCT DETAIL

Mayzent 2 mg filmom obalené tablety

Code 6381D
MA number EU/1/19/1414/006
Product Form: tbl flm 98x2 mg (PA/Al/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA42 Siponimod
Shelf life: 24
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 13.01.2020
Validity: 13.01.2025
SmPC + PL: European Medicines Agency's database
Dokument: Mayzent_Príručka pre pacienta.pdf  
Dokument: Mayzent_Kontrolný zoznam.pdf  
Safety feature Yes
Data update: 08.02.2021
eu-flag.png sk-flag.png